Send us Feedback

Eclipsys (ECLP)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

ECLP » Topics » Seasonality

These excerpts taken from the ECLP 10-K filed Feb 24, 2009.

Seasonality

Our revenues have historically been lower in the first quarter of the year and greater in the fourth quarter of the year; however, this did not occur in 2008, due primarily to the recent disruptions in the financial markets that adversely affected the availability of capital for our clients and our potential clients, which adversely affected revenue in the fourth quarter of 2008 as compared to the first quarter of 2008.

Seasonality

Our revenues have historically been lower in the first quarter of the year and greater in the fourth quarter of the year; however, this did not occur in 2008, due primarily to the recent disruptions in the financial markets that adversely affected the availability of capital for our clients and our potential clients, which adversely affected revenue in the fourth quarter of 2008 as compared to the first quarter of 2008.

Seasonality

Our
revenues have historically been lower in the first quarter of the year and greater in the fourth quarter of the year; however, this did not occur in 2008, due primarily to the recent disruptions in the financial markets that adversely affected the
availability of capital for our clients and our potential clients, which adversely affected revenue in the fourth quarter of 2008 as compared to the first quarter of 2008.

FACE="Times New Roman" SIZE="2">International

As of December 2008, our India operations include two offices and approximately 600 employees. We
believe that India provides access to educated professionals to work on software research, development and support, as well as other functions, at an economically effective cost and also represents a potential new market for our software.

We continue to focus on expanding our international business, including our operations in India and sales of our solutions outside of North America, such
as the Asia-Pacific region and the Middle East.

Seasonality

Our
revenues have historically been lower in the first quarter of the year and greater in the fourth quarter of the year; however, this did not occur in 2008, due primarily to the recent disruptions in the financial markets that adversely affected the
availability of capital for our clients and our potential clients, which adversely affected revenue in the fourth quarter of 2008 as compared to the first quarter of 2008.

FACE="Times New Roman" SIZE="2">International

As of December 2008, our India operations include two offices and approximately 600 employees. We
believe that India provides access to educated professionals to work on software research, development and support, as well as other functions, at an economically effective cost and also represents a potential new market for our software.

We continue to focus on expanding our international business, including our operations in India and sales of our solutions outside of North America, such
as the Asia-Pacific region and the Middle East.

These excerpts taken from the ECLP 10-K filed Feb 29, 2008.

Seasonality

Our revenues have historically been lower in the first quarter of the year and greater in the fourth quarter of the year.

Seasonality

STYLE="margin-top:6px;margin-bottom:0px">Our revenues have historically been lower in the first quarter of the year and greater in the fourth quarter of the year.

STYLE="margin-top:18px;margin-bottom:0px">International

We commenced operations in India in 2006, through an
acquisition of a small producer of laboratory software. By December 2007, our India operations, named Eclipsys (India) Private Limited, have expanded to include two offices and over 300 employees. We believe that India provides access to educated
professionals to work on research development and support of our software, at an economically effective cost.

In October 2007, SingHealth, the largest
healthcare provider in Singapore, selected Eclipsys Sunrise Clinical Manager as its electronic medical record platform. We are working to further expand into international markets.

FACE="Times New Roman" SIZE="2">Research and Development

We seek to maintain technological competitiveness and respond to market trends and our
clients’ evolving needs. Our software is based on Microsoft’s .NET Framework and other industry standards. We are also creating new functionality for our existing software. We have reduced our reliance on outside vendors that have
historically aided our internal personnel in software development. We use Microsoft’s Solutions Framework development methodology to gauge the quality and performance of our software development efforts. As part of these processes, we have also
involved clients in our software design process, enabling them in some cases to have direct and regular access to the development staff, including its senior leadership.

FACE="Times New Roman" SIZE="2">Our latest-generation clinical and access solutions utilize the same architecture and share the same Health Data Repository and many other components, while being adapted for the workflows of different
environments. This enables Eclipsys clients to tie together their workflows and operations across the entire continuum of care. Further, our software is built upon an open architecture that supports the secure exchange of data between
systems, as well as the ability to embed and present evidence-based content.

Our spending on research and development (including capitalized software
development costs) was $77.7 million, $71.9 million and $71.9 million in 2007, 2006 and 2005, respectively.

EXCERPTS ON THIS PAGE:

10-K (4 sections)
Feb 24, 2009
10-K (2 sections)
Feb 29, 2008

RELATED TOPICS for ECLP:

"Seasonality" elsewhere:

DivX (DIVX)
Digital Angel (DOC)
Drugstore.com (DSCM)
Datascope (DSCP)
Evans & Sutherland Computer (ESCC)
Ev3 (EVVV)
PC GROUP, INC. (GAIT)
HLTH (HLTH)
MTI Technology (MTIC)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki